Michelle Seywald is a Venture Analyst at Apollo Health Ventures, focusing on longevity and aging biotechnology. Her background includes engineering roles at Edwards Lifesciences and Stryker. She holds a prestigious MS/MBA dual degree in Biotechnology from Harvard, equipping her to bridge scientific innovation with business strategy.
Her dual degree from Harvard was specifically chosen to learn the business skills necessary to translate scientific discoveries into therapies that improve patients’ lives.
Michelle Seywald
Venture Analyst at Apollo Health Ventures
London, England, United Kingdom
Overview
Topics They Care About
Longevity Investing
As a Venture Analyst at Apollo Health Ventures, her primary focus is on aging and longevity biotechnology investments.
Biotech Commercialization
Pursued a dual MS/MBA from Harvard to learn how to translate scientific discoveries into viable patient therapies.
Medical Device Engineering
Has a background as a Clinical Development Engineer at Edwards Lifesciences and a Post-Market Design Engineer at Stryker.
Media Appearances
Michelle has no verified media appearances
Work History
3-2025
Venture Analyst at Apollo Health Ventures
9-2024 - 3-2025
Venture Labs Fellow at Apollo Health Ventures
7-2022 - 9-2024
MS/MBA Biotechnology: Life Sciences at Harvard Business School
11-2019 - 4-2022
Clinical Development Engineer II at Edwards Lifesciences
9-2017 - 5-2019
Post-Market Design Engineer at Stryker
7-2016 - 9-2017
Divisional Quality Engineer at Stryker
9-2014 - 5-2016
Research Assistant at Vo-Dinh Lab (Nanophotonics)
Education
7-2022 - 5-2024
MS/MBA Biotechnology Dual Degree from Harvard Business School
7-2022 - 5-2024
Master of Science - MS from Harvard Kenneth C. Griffin Graduate School of Arts and Sciences
More Information
Social Presence :
Prographics :
Exp : 10
Location : London, England, United Kingdom
Job Level : Middle
Designation : Venture Analyst at Apollo Health Ventures
